Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cells|June 25, 2026
Beyond Hydrogen Sulfide and Cysteine Metabolism: Reframing Cystathionine γ-Lyase as a Potential Translational Regulator of Hypoxia-Inducible Factor-1α in Clear Cell Ovarian CarcinomaAmal M El-Naggar
The Journal of Pathology|January 3, 2018
Translational control of aberrant stress responses as a hallmark of cancerAmal M El-Naggar, Poul H Sorensen
Cell Death & Disease|January 10, 2019
HACE1 is a potential tumor suppressor in osteosarcomaAmal M El-Naggar, Paul W Clarkson, Gian Luca Negri, et al.
BMC Cancer|May 3, 2026
Co-targeting cystathionine gamma-lyase and mTOR: a promising therapeutic strategy in clear cell ovarian cancerLongyijie Wei, Amal M El-Naggar, Yuqin Li, et al.
Communications Biology|May 10, 2019
Pharmacological systems analysis defines EIF4A3 functions in cell-cycle and RNA stress granule formationAlborz Mazloomian, Shinsuke Araki, Momoko Ohori, et al.
EMBO Reports|November 1, 2019
Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasisAmal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang, et al.
Cancer Research|May 6, 2020
HACE1 Prevents Lung Carcinogenesis via Inhibition of RAC-Family GTPasesMelanie Kogler, Luigi Tortola, Gian Luca Negri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2023
Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing SarcomaBrian Mooney, Gian Luca Negri, Taras Shyp, et al.
Cancer Cell|May 13, 2015
Translational Activation of HIF1α by YB-1 Promotes Sarcoma MetastasisAmal M El-Naggar, Chansey J Veinotte, Hongwei Cheng, et al.
The Journal of Pathology|May 15, 2025
Cystathionine gamma-lyase-mediated hypoxia inducible factor 1-alpha expression drives clear cell ovarian cancer progressionAmal M El-Naggar, Yuqin Li, Busra Turgu, et al.
Pageof 2